264 related articles for article (PubMed ID: 15705254)
1. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
Maron BJ
Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254
[No Abstract] [Full Text] [Related]
2. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
O'Mahony C; Elliott PM
Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
[No Abstract] [Full Text] [Related]
3. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
Maron BJ
Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
[No Abstract] [Full Text] [Related]
4. Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
[No Abstract] [Full Text] [Related]
6. [Sudden death in hypertrophic myocardiopathy].
Cardim N; Longo S; Gouveia D; Lousada N; Ferreira T; Pereira AT; Correia JM
Rev Port Cardiol; 1995 Sep; 14(9):655-9. PubMed ID: 7576766
[TBL] [Abstract][Full Text] [Related]
7. [Syncope of uncertain cause and sudden cardiac death in young patients].
Schimpf R; Wolpert C; Veltmann C; Kuschyk J; Borggrefe M
Dtsch Med Wochenschr; 2006 May; 131(18):1040-6. PubMed ID: 16673231
[No Abstract] [Full Text] [Related]
8. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
[No Abstract] [Full Text] [Related]
9. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
Maron BJ; Olivotto I; Maron MS
Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
[No Abstract] [Full Text] [Related]
10. Sudden death in hypertrophic cardiomyopathy.
Watkins H
N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
[No Abstract] [Full Text] [Related]
11. My approach to clinical management of hypertrophic cardiomyopathy.
Maron MS
Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
[No Abstract] [Full Text] [Related]
12. Device therapy in hypertrophic cardiomyopathy.
Beadle R; Williams L
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
[TBL] [Abstract][Full Text] [Related]
13. Sudden cardiac death in hypertrophic cardiomyopathy.
Malanuk RM; Nielsen CD; Spencer WH
J S C Med Assoc; 2001 Oct; 97(10):424-7. PubMed ID: 11688312
[No Abstract] [Full Text] [Related]
14. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
[No Abstract] [Full Text] [Related]
15. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
16. Implantable defibrillators in hypertrophic cardiomyopathy.
Grace A
Heart; 2009 May; 95(9):695-6. PubMed ID: 19282312
[No Abstract] [Full Text] [Related]
17. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
Maron BJ
Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
[No Abstract] [Full Text] [Related]
18. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
Cotiga D; Ehlert F; Sherrid M
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
[TBL] [Abstract][Full Text] [Related]
19. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment in hypertrophic cardiomyopathy.
Saumarez RC
Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
